Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 2
2006 1
2007 2
2008 2
2009 2
2010 4
2011 3
2012 2
2013 2
2014 3
2015 3
2016 4
2017 7
2018 5
2019 8
2020 6
2021 7
2022 4
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Snacking in nutrition and health.
Marangoni F, Martini D, Scaglioni S, Sculati M, Donini LM, Leonardi F, Agostoni C, Castelnuovo G, Ferrara N, Ghiselli A, Giampietro M, Maffeis C, Porrini M, Barbi B, Poli A. Marangoni F, et al. Among authors: leonardi f. Int J Food Sci Nutr. 2019 Dec;70(8):909-923. doi: 10.1080/09637486.2019.1595543. Epub 2019 Apr 10. Int J Food Sci Nutr. 2019. PMID: 30969153 Free article. Review.
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Qin S, et al. Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871608 Clinical Trial.
Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review.
Pellegrino B, Sikokis A, Bersanelli M, Leonetti A, Leonardi F, Di Meglio G, Buti S. Pellegrino B, et al. Among authors: leonardi f. Gynecol Obstet Invest. 2016;81(5):385-93. doi: 10.1159/000446954. Epub 2016 Jun 17. Gynecol Obstet Invest. 2016. PMID: 27309542 Review.
The role of the microbiome in drug resistance in gastrointestinal cancers.
Garajová I, Balsano R, Wang H, Leonardi F, Giovannetti E, Deng D, Peters GJ. Garajová I, et al. Among authors: leonardi f. Expert Rev Anticancer Ther. 2021 Feb;21(2):165-176. doi: 10.1080/14737140.2021.1844007. Epub 2020 Dec 8. Expert Rev Anticancer Ther. 2021. PMID: 33115280 Review.
The implication of liquid biopsies to predict chemoresistance in pancreatic cancer.
Pietri E, Balsano R, Coriano M, Gelsomino F, Leonardi F, Bui S, Gnetti L, Valle RD, Garajová I. Pietri E, et al. Among authors: leonardi f. Cancer Drug Resist. 2021 Apr 14;4(3):559-572. doi: 10.20517/cdr.2021.01. eCollection 2021. Cancer Drug Resist. 2021. PMID: 35582309 Free PMC article. Review.
Revealing invisible cell phenotypes with conditional generative modeling.
Lamiable A, Champetier T, Leonardi F, Cohen E, Sommer P, Hardy D, Argy N, Massougbodji A, Del Nery E, Cottrell G, Kwon YJ, Genovesio A. Lamiable A, et al. Among authors: leonardi f. Nat Commun. 2023 Oct 11;14(1):6386. doi: 10.1038/s41467-023-42124-6. Nat Commun. 2023. PMID: 37821450 Free PMC article.
Fingerprint Change: Not Visible, But Tangible.
Negri FV, De Giorgi A, Bozzetti C, Squadrilli A, Petronini PG, Leonardi F, Bisogno L, Garofano L. Negri FV, et al. Among authors: leonardi f. J Forensic Sci. 2017 Sep;62(5):1372-1373. doi: 10.1111/1556-4029.13422. Epub 2017 Jun 12. J Forensic Sci. 2017. PMID: 28605025
68 results